Key Points
-
Flaviviruses and hepaciviruses share similarities in their fundamental replication mechanisms and strategies to manipulate the host cell, yet important differences exist, likely reflecting the use of distinct host cell pathways.
-
RNA replication of Flaviviridae family members occurs in tight association with endoplasmic reticulum-derived membranes, which are reorganized into viral replication organelles. Whereas the morphology and the architecture of these replication organelles are well defined, relatively little is known about the viral and cellular factors orchestrating their biogenesis.
-
Protein folding, modification and degradation are essential, tightly regulated cellular processes, and a number of common host factors and pathways that are involved in these processes appear to be exploited by both flaviviruses and hepaciviruses at different steps of their replication cycle. These include heat shock protein 70 (HSP70) network components, the unfolded protein response, the ubiquitin-dependent proteasome system and autophagy.
-
Accumulating evidence indicates that lipids and lipid metabolism fulfil essential roles in the life cycle of Flaviviridae viruses. They alter the lipid composition of cellular membranes, serving as scaffold for the assembly of the viral replicase by changing their biophysical properties, such as curvature, permeability and fluidity.
-
The identification of host cell pathways and factors commonly used by members of the Flaviviridae family might help in the development of broad-spectrum antiviral drugs that target multiple members of this family and/or other virus families.
-
As exemplified by members of the Flaviviridae family, the use of host cell pathways does not follow conventional phylogeny but, rather, reveals unexpected commonalities with distantly related viruses, raising the question of evolutionary relationships between these viruses.
Abstract
Members of the Flaviviridae virus family comprise a large group of enveloped viruses with a single-strand RNA genome of positive polarity. Several genera belong to this family, including the Hepacivirus genus, of which hepatitis C virus (HCV) is the prototype member, and the Flavivirus genus, which contains both dengue virus and Zika virus. Viruses of these genera differ in many respects, such as the mode of transmission or the course of infection, which is either predominantly persistent in the case of HCV or acutely self-limiting in the case of flaviviruses. Although the fundamental replication strategy of Flaviviridae members is similar, during the past few years, important differences have been discovered, including the way in which these viruses exploit cellular resources to facilitate viral propagation. These differences might be responsible, at least in part, for the various biological properties of these viruses, thus offering the possibility to learn from comparisons. In this Review, we discuss the current understanding of how Flaviviridae viruses manipulate and usurp cellular pathways in infected cells. Specifically, we focus on comparing strategies employed by flaviviruses with those employed by hepaciviruses, and we discuss the importance of these interactions in the context of viral replication and antiviral therapies.
Similar content being viewed by others
Introduction
As obligate intracellular parasites, viruses strictly depend on their ability to manipulate the machinery of host cells to propagate. Consequently, viruses have evolved numerous strategies to manipulate infected cells by triggering a series of metabolic and structural changes that facilitate viral replication.
The Flaviviridae family provides many fascinating examples of virus-driven cellular reprogramming. This family is composed of four genera: Flavivirus (with 53 species); Hepacivirus (with 14 species); Pegivirus (with 11 species) and Pestivirus (with 4 species)1. Several members within the Hepacivirus and Flavivirus genera have a substantial impact on human health. Chronic infection by hepatitis C virus (HCV), the prototypic hepacivirus, is the leading cause of liver disease worldwide, with ∼71 million individuals at risk of developing liver cirrhosis and hepatocellular carcinoma2. Recently, highly effective direct-acting antiviral drugs targeting essential viral processes have become available for clinical use; however, a prophylactic vaccine to control the HCV pandemic is still missing (reviewed in Ref. 3). In contrast to the predominantly persistent infection by HCV, human infections with flaviviruses are acute and self-limiting and are either asymptomatic or present as an undifferentiated febrile illness that can, in specific cases, lead to more severe symptoms, such as vascular leakage, severe haemorrhage, shock or serious neurological complications, such as encephalitis and meningitis. Dengue virus (DENV), the aetiological agent of dengue fever and dengue haemorrhagic fever, or dengue shock syndrome, is responsible for an estimated 60 million symptomatic infections annually, causing approximately 10,000 deaths per year4. Although a DENV vaccine has recently been licensed, its overall efficacy is limited, especially in immunologically naive individuals, and its administration is not recommended for young children or elderly people, both of whom have a higher risk of serious disease5.
Examples of neurotrophic flaviviruses include West Nile virus (WNV), tick-borne encephalitis virus (TBEV), Japanese encephalitis virus (JEV) and Zika virus (ZIKV). The latter has recently spread worldwide, and infections have been linked to Guillain–Barré syndrome in adults and multiple neurodevelopmental defects, including microcephaly in infants born to mothers infected during the first trimester of pregnancy (reviewed in Ref. 6). Although ZIKV is rarely neuroinvasive in adults, it can infect human neural progenitor cells (hNPC), likely resulting in the congenital disorders mentioned above (reviewed in Ref. 7). At present, no approved antiviral drugs are available for the treatment of Flavivirus infections.
In addition to the marked differences in tropism and pathogenesis, viruses within the Flavivirus and Hepacivirus genera, while sharing similarities in their overall genome organization, differ in several respects, such as their mechanism of translation: a canonical, cap-dependent pathway in the case of flaviviruses or an internal ribosome entry site (IRES) in the case of HCV (Fig. 1). Along the same line, the general principle of the replication cycles of flaviviruses and hepaciviruses is similar (Box 1 and Box 2, respectively), but multiple differences have been discovered during the past few years, including the dependency on a specific lipid kinase in the case of HCV but not DENV or ZIKV. These differences and similarities reflect the strategies that are used by these viruses to manipulate host cells, offering the opportunity to learn about the roles of host cell factors, pathways and the mechanisms of their manipulation by conducting comparative analyses. In this Review, we summarize the current understanding of how members of the Flaviviridae family take control of cellular components or processes in order to create environments that are favourable for viral replication. We will compare and contrast DENV and ZIKV with HCV as representatives of the Flavivirus and Hepacivirus genera, respectively. Understanding the details of how viruses exploit their host cells opens new avenues for the development of antiviral strategies, and comparing replication strategies within the Flaviviridae may help us to identify shared essential host-dependency factors that are suitable for the development of broad-spectrum antivirals with pan-flaviviral activity.
The ORF encoding the dengue virus (DENV) (part a) or hepatitis C virus (HCV) (part b) polyprotein and the predicted secondary structures of the 5′ and 3′ non-translating regions (NTR) are depicted on the top of each panel. a | The DENV genome contains a type 1 cap structure at the 5′ end. Polyprotein cleavage by cellular signal peptidases is indicated by scissors. Arrows denote the cleavage by the viral protease, whereas the black vertical arrow indicates cleavage by the Golgi apparatus-resident protease furin. The question mark denotes a DENV polyprotein cleavage performed by an unknown protease. The DENV structural proteins capsid protein C, prM and envelope protein E are constituents of the virion; NS1, the only non-structural protein residing in the lumen of the endoplasmic reticulum (ER), and NS2A are essential for virus replication and production of infectious particles; serine protease subunit NS2B acts as a cofactor for serine protease NS3 and recruits NS3 to ER membranes; NS3 is a multifunctional protein with protease, nucleotide 5′ triphosphatase (NTPase), RNA 5′ triphosphatase and helicase activities; NS4A is an integral membrane protein with membrane curvature-inducing activity; the 2K peptide serves as a signal peptide for co-translational NS4B insertion into the ER membrane; NS4B is a protein with no reported enzymatic activity that interacts with NS3 and is absolutely required for virus replication; NS5 consists of an N-terminal domain that possesses guanylyltransferase, guanine-N7-methyltransferase and nucleoside-2′-O-methyltransferase activities involved in 5′-RNA capping and methylation of the viral genome, and a C-terminal domain with RNA-dependent RNA polymerase activity responsible for viral RNA synthesis. b | The HCV RNA genome is ∼9.6 kb long, uncapped and flanked by highly structured 5′ and 3′ NTRs. The 5′ NTR contains a type III internal ribosome entry site (IRES) that directs the cap-independent translation of the viral RNA genome. Polyprotein cleavage by the viral protease is indicated by arrows, whereas cleavage by cellular signal peptidases is indicated by scissors. The cleavage by the cellular signal peptide peptidase resulting in the removal of the HCV core carboxy- terminal region is indicated by an asterisk. The core protein and the envelope glycoproteins E1 and E2 constitute the viral particle, whereas p7 and NS2 support particle assembly yet are not incorporated into virions; the NS2 C-terminal domain contains a cysteine protease that catalyses the cleavage of the NS2–NS3 junction; NS3 contains serine protease, RNA helicase and NTPase activities; NS4A acts as cofactor for the NS3 protease and anchors NS3 to ER membranes; NS4B is involved in the formation of the HCV replication organelle; NS5A is a phosphoprotein with an intrinsically unfolded C-terminal region that mediates interactions with numerous cellular proteins; NS5B is the viral RNA-dependent RNA polymerase responsible for RNA synthesis. Note that only the DENV capsid and NS1 as well as HCV NS5A are shown as dimers, but additional viral proteins form homodimers and heterodimers or oligomeric complexes. AUG, methionine (start codon); D1, domain 1. Part b is adapted from Ref. 39, Macmillan Publishers Limited.
Architecture of replication organelles
Replication of the genome of positive-strand RNA ((+)RNA) viruses occurs in close association with cellular endomembranes within organelle-like structures defined as replication organelles (ROs). These ROs serve to increase the local concentration of cellular and viral factors that are required for genome replication, coordinate the different steps of viral replication through their compartmentalization and to shield genomic RNA from cellular innate immune sensors. ROs can be grouped into two morphologically distinct classes designated as invaginated/spherule-type ROs or protrusion-type ROs. Invaginated/spherule-type ROs are generated by invaginations of the donor membrane into the organelle lumen. The protrusion-type ROs are composed of clusters of single-membrane vesicles (SMVs), double-membrane vesicles (DMVs), multimembrane vesicles (MMVs) and often multimembrane tubules. Interestingly, although donor membranes can be provided by different organelles, ROs from all (+)RNA viruses can be classified into one of these two morphotypes, suggesting evolutionarily conserved mechanisms of their biogenesis8.
In the case of flaviviruses, electron microscopy analysis of cells infected with DENV or ZIKV revealed the formation of clusters of vesicles ∼90 nm in diameter, defined as vesicle packets (VPs), that are created by the invagination of rough endoplasmic reticulum (ER) membranes (Fig. 2A). Additionally, bundled smooth ER membranes, termed convoluted membranes (CMs), are often observed in close proximity to mitochondria (see below) and VPs9,10,11. VPs and CMs are interconnected and form a single endomembrane network9. A pore-like opening of ∼11 nm connects the vesicle interior with the cytosol, presumably to allow for the exchange of metabolites and other molecules (Fig. 2A, inset). The detection of viral replicase components and double-stranded RNA (dsRNA) replication intermediates within invaginated vesicles suggests that VPs are the site of viral genome amplification9. Virions bud within ER cisternae opposed to the pores of invaginated vesicles, and clusters of virions can often be observed in paracrystalline arrays in enlarged ER cisternae in close proximity to VPs.
A | Architecture of Flavivirus replication organelles. Aa | Three-dimensional surface rendering of dengue virus (DENV) and Zika virus (ZIKV) replication compartments. The endoplasmic reticulum (ER) is shown in brown and blue for DENV and ZIKV, respectively. Virus-induced vesicles are in light brown for DENV and dark blue for ZIKV. Virus particles are depicted in red (DENV) and gold (ZIKV). Ab | Schematic representation of the Flavivirus replication and assembly compartments. Genome replication occurs within vesicle packets (VPs) formed upon ER membrane invagination. Pore-like openings connect the interior of vesicles with the cytosol to allow for metabolite exchange and trafficking of the newly synthesized RNA genome. Virions assemble through nucleocapsid budding within ER cisternae close to VPs. Particles arrange in crystalline arrays within swollen ER cisternae connected to VPs. Ac | Model of Flavivirus-induced vesicle biogenesis. Negative membrane curvatures might be induced by non-structural protein 4A (NS4A) and NS4B amphipathic α-helices that are partially embedded within the ER luminal membrane leaflet. Negative curvature might be stabilized by homo-oligomerization and hetero-oligomerization between NS4A and NS4B along with interaction with NS1 dimers associated with the luminal side of the vesicle. NS2A and other host factors might further contribute to induce membrane alterations and stabilize the pore-like opening. B | Architecture of Hepacivirus replication organelles. Ba | Hepatitis C virus (HCV) membranous web as revealed by electron tomography and three-dimensional reconstruction of infected cells. The ER is shown in dark brown. Double-membrane vesicle (DMV) outer membranes are depicted in light brown and inner membranes in orange. Cytoskeletal filaments, Golgi apparatus cisternae and single-membrane vesicles (SMVs) are shown in blue, green and violet, respectively. Bb | Schematic representation of the HCV replication and assembly compartment. DMVs form as ER protrusions and contain the non-structural proteins that are responsible for viral genome replication. Replicase activity might cease upon vesicle closure (grey shaded vesicle). Alternatively, the viral replicase might be associated with the exterior of DMVs. Newly synthetized RNA might be delivered to assembly sites by NS5A and serine protease NS3 in a process assumed to involve core protein-loaded cytosolic lipid droplets. Formation of nucleocapsids is concomitant with particle budding into the ER lumen. Bc | Model of HCV-induced DMV biogenesis. The amphipathic α-helices and the oligomerization capabilities of the replicase proteins NS4B and NS5A, perhaps along with components of the autophagy machinery (not shown), might promote positive membrane curvature and DMV formation. MMVs, multimembrane vesicles. Part Aa is adapted with permission from Refs 9,10, Elsevier. Part Bb is adapted from Ref. 16.
The specific function of CMs in viral infection is still unclear. An enrichment for viral proteins but not dsRNA in these cellular structures suggests that CMs are sites of polyprotein maturation12. CMs could also serve as lipid storage sites or interfere with innate immune responses by disrupting the mitochondria-associated membranes (MAMs), an important interface for innate immune signalling, or by sequestering innate immune pattern recognition receptors (PRRs)9,13,14. However, the absence of such structures in either DENV-infected mosquito cells15 or ZIKV-infected hNPCs10 questions a general function for CMs in viral replication and argues for a cell type-specific role. In addition to VPs and CMs, tightly juxtaposed ER cisternae with limited luminal area, termed zippered ER (zER) membranes, are often observed in ZIKV-infected hepatoma cells10. Interestingly, in hNPCs infected with ZIKV, neither CMs nor zERs are formed, and the average diameter of VPs is considerably smaller (∼60 nm versus ∼90 nm in hepatoma cells), suggesting that cell type-specific factors help determine the architecture of ZIKV ROs.
In contrast to flaviviruses, HCV induces the production of ∼150 nm diameter DMVs16, forming clusters designated as the membranous web (Fig. 2B). Membranous web formation can be induced by the synthesis of the viral replicase proteins non-structural protein 3 (NS3) to NS5B independent of viral RNA replication. The DMV outer membrane is often linked to the ER, suggesting that DMVs originate as protrusions that extend from the ER towards the cytosol16 (Fig. 2B, inset). In addition to DMVs, SMVs and MMVs can also be observed within the membranous web (Fig. 2B). Though the contribution of SMVs to the viral replication cycle is still unclear, MMVs have been shown to form after the formation of DMVs and might represent a replication by-product or arise as the result of a cellular stress response17.
The correlation between DMV abundance and RNA amplification, as well as the presence of replicase activity in isolated DMVs18, suggests that DMVs constitute the site of HCV RNA replication. However, it is not yet possible to unambiguously localize the site of de novo RNA synthesis to either the lumen or to the outer membrane of DMVs. Biochemical studies have showed that HCV RNA and replicase activity reside within a nuclease-resistant and protease-resistant environment18,19,20, supporting the hypothesis that replication occurs within the membrane-protected luminal side of DMVs. Exchange of metabolites and factors that are required for replication, as well as the exit of newly synthesized genomes from DMVs, could occur through pore-like openings, which were observed in ∼10% of the vesicles. This would suggest that only a minor proportion of the DMVs supports active replication at a given time point and that replication might cease when membrane openings are closed16. Alternatively, proteinaceous transport complexes, such as nuclear pore complex-like structures, might enable traffic in and out of a closed membrane compartment21,22.
Biogenesis of replication organelles
Whereas the morphology and the architecture of Flavivirus ROs are well-defined, relatively little is known about the molecular mechanisms governing the biogenesis of VPs and CMs. In the case of DENV, available evidence argues for a prominent role of the two small non-structural proteins NS4A and NS4B in the formation of ROs. Both proteins possess multiple transmembrane spanning α-helices and a single amphipathic α-helix that is partially embedded into the luminal leaflet of the ER8 (Figs 1a,2A). The lipid bilayer asymmetry that is produced by the α-helix insertion might act as a wedge and induce negative membrane curvature. Moreover, membrane bending might be increased by the formation of NS4A and NS4B homo-oligomers and hetero-oligomers23. However, the individual or combined expression of NS4A and NS4B outside the context of viral infection does not induce the formation of VPs, suggesting that the membrane remodelling functions of these proteins are not sufficient to phenocopy DENV ROs and that additional viral factors are required. Owing to its analogy to alphaviruses and the Flock House virus, viral RNA could be one candidate factor24,25,26.
Several reports have also suggested roles for non-structural proteins NS1 and NS2A in the formation of Flavivirus VPs. NS1 interacts with both NS4A and NS4B (Fig. 2A), and recombinant NS1 interacts with and remodels lipids in vitro27,28. NS2A is a small hydrophobic protein with five transmembrane α-helices that can alter membrane permeability29. In addition, NS2A is enriched in subcellular regions containing viral dsRNA and may interact with replicase proteins29. Together, these results support a model in which oligomers of NS4A and NS4B, and possibly NS2A, induce negative membrane curvature, with NS1 dimers present within the ER lumen promoting positive membrane curvature and assisting in the formation of invaginated vesicles (Fig. 2A, inset). Additionally, host factors such as components of the endosomal sorting complex required for transport (ESCRT) machinery appear to have a role in the formation of VPs, for example, by participating in the assembly of the vesicle pore30.
The concerted action of the viral replicase complex proteins, together with tightly regulated polyprotein cleavage, is required for the formation of the HCV membranous web (reviewed in Ref. 8). Key contributors to its biogenesis are NS4B and NS5A16,31. The complex topology of NS4B, which is comprised of four transmembrane α-helices flanked by two amphipathic α-helices on either side (Fig. 1b), together with its oligomerization capabilities, may support and promote positive membrane curvature32. Moreover, essential residues for DMV formation and RNA replication have been identified within the NS4B carboxy-terminal domain33. Regarding NS5A, it is the only HCV protein able to induce DMVs16, a process that is facilitated by determinants that are located within the membrane-associated amino-terminal amphipathic α-helix of NS5A domain 1 (Ref. 31). Furthermore, NS5A recruits several host factors that are essential for membranous web formation34,35,36. Finally, NS5A inhibitors as well as antagonists of cyclophilin A, a chaperone that binds to NS5A, block membranous web formation, highlighting its essential role in the biogenesis of HCV ROs34,37.
Rewiring cellular pathways
The generation of a host cell environment that is permissive to viral replication requires the utilization of numerous host cell pathways. Viruses can either use these pathways without manipulating them or they can hijack or change host cell pathways to benefit virus replication. Examples for both of these scenarios have been observed for components of the host cell protein synthesis and processing pathways in infections caused by members of the Flaviviridae virus family.
Protein processing and folding
Protein processing and modification. All Flaviviridae viruses utilize cellular signal peptidases for proper cleavage of the viral polyprotein, specifically for the liberation of viral structural proteins (Fig. 1). For instance, Flavivirus structural proteins are released from the viral polyprotein by host signal peptidase, and HCV structural proteins are cleaved by both signal peptidase and signal peptide peptidase38,39. Of interest, efficient viral protease cleavage of the Flavivirus capsid (removal of the C-terminal membrane anchor to generate mature capsid protein) is required for efficient cleavage of the capsid–prM precursor by signal peptidase40. Moreover, uncoupling the sequential order of the two cleavages impairs nucleocapsid incorporation into virions, arguing that the coordination of virus particle production is regulated by polyprotein processing41,42,43. A recent study demonstrated that individual components of the signal peptidase complex have specificity for specific polyprotein cleavage sites, indicating that individual components of this complex might represent targets for directed pharmacological inhibition of viral replication44. Indeed, cavinafungin, a compound that antagonizes signal peptidase activity, has been shown to inhibit DENV and ZIKV propagation45.
The role of viral protein glycosylation in the replication cycle of Flaviviridae family members has been well characterized, as glycoproteins are important for virion structure and stability. Specifically, glycosylation of proteins affects almost every step of the viral life cycle, including evasion from humoral immune responses (reviewed in Refs 46,47), and inhibitors of the glucose-trimming enzymes α-glucosidase I and II are currently being tested in clinical trials for their potential to treat DENV infection (Box 3). In addition, a recent study demonstrated that specific subunits of the oligosaccharyltransferase (OST) complex, but not its enzymatic activity, are required for mosquito-borne Flavivirus infection, whereas no role has been identified in HCV replication48. Moreover, this study shows that the OST complex subunits STT3A and STT3B interact with DENV non-structural proteins and are specifically required for viral RNA replication48. The importance of the OST complex for Flavivirus replication is also supported by a more recent study, which demonstrated that, though STT3A and STT3B enzymatic activity is not required for DENV propagation, the enzymatic activity of the non-canonical OST complex subunit, magnesium transporter protein 1 (MAGT1), is important for DENV replication49.
Protein folding and chaperones. Replication of Flaviviridae family members also relies on host cell chaperones for proper synthesis and folding of the viral proteins. Indeed, numerous chaperones are reported to be required for specific steps of Flaviviridae replication cycles. For instance, heat shock protein 70 (HSP70) functions at many stages of the Flavivirus replication cycle, from virion entry into host cells to assembly and the release of viral particles50 (reviewed in Ref. 51). Interestingly, the function of HSP70 in different viral processes seems to be determined by one of nine co-chaperones called DNAJ proteins50. In the case of DENV, HSP70 cofactors DNAJ homologue subfamily B member 11 (DNAJ11) or DNAJB6 promote either viral replication or particle biogenesis, respectively, whereas DNAJC14 has antiviral activity against both DENV and the yellow fever virus (YFV)50,52,53. Importantly, inhibition of the HSP70–DNAJ network with the inhibitory drug JG40 significantly decreased virus replication for multiple DENV serotypes as well as WNV, YFV and tick-borne encephalitis virus (TBEV)50. Currently, there is little information on the involvement of host cell chaperones in ZIKV infection. However, the conserved requirement for these proteins by other Flaviviridae family members suggests that components of the host cell molecular chaperone network will likely also have a role in the ZIKV replication cycle.
In HCV-infected cells, viral proteins interact with multiple components of the HSP90 and HSP70 chaperone networks, and the function of these chaperones is required at various stages in virus infection54,55,56,57,58. Specifically, NS5A is reported to form a complex with both HSP70 and heat shock cognate 71 kDa protein (HSC70; also known as HSPA8); the former being required for viral protein synthesis and the latter having a role in virion assembly55,56,57. Inhibition of the different HSP70 network components, either through protein depletion or by addition of specific inhibitors, blocks viral protein synthesis or virus assembly54,56. This conserved requirement for chaperones in the replication cycles of viruses makes them a promising target for the development of antiviral drugs that might be effective against multiple viruses. An example of this are cyclophilins (CYPs); the CYP chaperone activity, especially CYPA, was shown to be crucial for HCV replication and has been used with clinical success as a drug target for the treatment of chronic HCV infection59 (Box 3).
The unfolded protein response. High levels of viral RNA and proteins in infected cells causes increased cellular stress, leading to the activation of cellular pathways that mitigate stress and promote cell survival or trigger apoptosis (Fig. 3A). The unfolded protein response (UPR) is a pathway aimed at compensating for increases in ER stress by increasing the ER protein-folding capacity, attenuating mRNA production and stimulating the ER-associated degradation (ERAD) of misfolded proteins. Initiation of the UPR is facilitated by the interaction of immunoglobulin heavy chain-binding protein (BiP) with one of three ER sensors: serine/threonine-protein kinase/endoribonuclease (IRE1), eukaryotic translation initiation factor 2-α kinase 3 (PERK; also known as EIF2AK3) and cyclic AMP-dependent transcription factor ATF6-α (ATF6)60. Additionally, UPR activation leads to increased autophagy, oxidative stress and stress granule formation and has been linked to the potentiation of antiviral inflammatory responses61,62,63,64,65,66,67. If these mechanisms are not effective at restoring ER homeostasis, active UPR pathways lead to apoptosis.
A | Expression of the viral proteins during hepatitis C virus (HCV) and dengue virus (DENV) infection recruits immunoglobulin heavy chain-binding protein (BiP), resulting in depletion of BiP from the endoplasmic reticulum (ER)-stress sensors cyclic AMP-dependent transcription factor ATF6-α (ATF6), serine/threonine-protein kinase/endoribonuclease IRE1 and eukaryotic translation initiation factor 2-α kinase 3 (PERK). Aa | These BiP-less sensors become activated to induce the unfolded protein response (UPR) pathway. HCV and DENV have developed strategies to manipulate UPR pathways to promote virus replication (see main text for details). B | Manipulation of the cellular degradation pathways. Ba | HCV, DENV and Zika virus (ZIKV) infection induce proteasome-mediated degradation of innate signalling proteins to dampen the antiviral immune response. Bb | Viral infection triggers autophagy and alters the autophagy flux. Bc | For instance, established DENV infection suppresses the autophagic flux, blocking the fusion between autophagosomes and lysosomes. Bd | HCV non-structural proten 4B (NS4B) interacts with autophagy protein 5 (ATG5) and recruits the autophagosome membrane elongation complex (ATG5–ATG12–ATG16L1) to the membranous web, contributing to its formation. Be | In addition to general autophagy, selective autophagic pathways are hijacked during Flaviviridae infection (see main text for details). C | Subversion of lipid homeostasis. Ca | DENV serine protease NS3 recruits fatty acid synthase (FASN) to replication compartments to stimulate lipid biosynthesis. De novo synthesized fatty acids are incorporated into replication organelles (ROs). 3-Hydroxy-3-methylglutaryl-CoA reductase (HMGCR) is recruited to DENV ROs, where it colocalizes with NS4A. Inactivation of the protein kinase 5′-AMP-activated protein kinase (AMPK) during DENV infection enhances HMGCR enzymatic activity, which results in higher cholesterol levels within ROs. Cb | During HCV infection, both viral proteins and regulatory elements within the 3′ UTR of the viral genome activate the transcription of lipogenic genes through sterol regulatory element-binding protein (SREBP)-mediated pathways (see main text for details). Cc | HCV NS5A and NS5B recruit and stimulate phosphatidylinositol 4-kinase-α (PI4KA) activity, thus increasing the local concentration of phosphatidylinositol-4- phosphate (PtdIns4P). Lipid transfer proteins such as oxysterol-binding protein 1 (OSBP) bind to PtdIns4P-rich membranes and release cholesterol in exchange for PtdIns4P. ATF4, cyclic AMP-dependent transcription factor ATF-4; ATG12, ubiquitin-like protein ATG12; ATG16L1, autophagy-related protein 16-like 1; CBP, CREB-binding protein; DDX3X, ATP-dependent RNA helicase DDX3X; eIF2α, eukaryotic translation initiation factor 2 subunit 1; ERAD, ER-associated degradation; FAM134B, reticulophagy regulator 1; IKKα, inhibitor of nuclear factor-κB kinase subunit-α; LC3, microtubule-associated proteins 1A/1B light chain 3B (also known as MAP1LC3B); p300, histone acetyltransferase p300; STAT1, signal transducer and activator of transcription 1; STAT2, signal transducer and activator of transcription 2; STAT3, signal transducer and activator of transcription 3; XBP1, X-box-binding protein 1.
Activation of all three UPR pathways has been reported for DENV and HCV infections both in patient samples and in cell culture models, and several UPR proteins have been identified as important factors in Flaviviridae infection68 (reviewed in Refs 60,69,70) (Fig. 3A). For DENV infection, a time-dependent induction of each UPR pathway has been reported71. At early stages of infection, the PERK pathway is activated, leading to a translational block through the phosphorylation of eukaryotic translation initiation factor 2 subunit 1 (eIF2α), an event that also leads to the production of cytoplasmic stress granules71,72. DENV overcomes this block and antagonizes stress granule formation by reversing eIF2α phosphorylation, presumably through the activation of the negative feedback factor protein phosphatase 1 regulatory subunit 15A (GADD34; also known as PPP1R15A) (Refs 71,73). Interestingly, a recent report demonstrated that DENV potentiates a host cell translational block by stimulating eIF4E phosphorylation, which in turn limits cap-dependent translation72. This translational repression did not decrease viral protein synthesis, supporting a model in which DENV can switch between cap-dependent and cap-independent translation during infection72,74.
PERK activation has also been observed for HCV infection both in patient samples and cell culture systems. However, contrasting reports have suggested that HCV both stimulates and represses eIF2α phosphorylation (Fig. 3A), and it has been proposed that the IRES mediates RNA translation in an eIF2α-dependent or eIF2α-independent manner, depending on the abundance of active eIF2α (reviewed in Refs 75,76). Additionally, oscillating stress granule formation has been observed in HCV infection, which has been suggested to be a result of eIF2α phosphorylation73. This flexibility in translation strategies may confer HCV the ability to overcome some of the host cell antiviral strategies, thus promoting persistence73.
Increasing levels of DENV structural proteins cause UPR activation via IRE1 with two major outcomes: induction of the regulated IRE1-dependent decay (RIDD) pathway and stimulation of X-box-binding protein 1 (XBP1) mRNA splicing to make XBP1 (Ref. 71). XBP1 is then translocated to the nucleus where it acts as a transcription factor, facilitating the activation of the ERAD pathways and stimulating expansion of the ER membrane, both of which help to alleviate DENV-induced ER stress77,78. DENV has developed mechanisms to block the downstream apoptotic mediators of the IRE1 pathway, thereby taking advantage of the prosurvival properties of this pathway to enhance viral replication (reviewed in Ref. 70). Whereas the IRE1 pathway is also activated by HCV infection and might have a proviral function, mainly through the induction of autophagy (see below), in the case of DENV IRE1-mediated XBP1, activation causes membrane expansion that is important for viral replication and is possibly involved in the formation of VPs.
In addition to IRE1, the ATF6 branch of the UPR is activated by both DENV and HCV infection (Fig. 3A), and in both cases, this pathway has proviral activity71,79,80. In combination with the IRE1 pathway, ATF6 activation also stimulates ERAD, although ATF6 activation is associated with lower levels of ER stress, whereas IRE1 activation occurs under higher levels of stress81. Taken together, these studies suggest that Flaviviridae members must maintain a balance between activation and suppression of host cell stress responses to maintain cell survival, avoid immune activation and ensure efficient viral protein production. Thus, tipping this balance in one direction could be an important tool for manipulating viral replication.
Protein degradation
The ubiquitin-dependent proteasome system (UPS) and autophagy are the two main cellular degradation pathways that are responsible for protein homeostasis. Both pathways are involved in the cellular defence against viral infections and, therefore, viruses have evolved mechanisms to manipulate these protein degradation pathways for their benefit.
Ubiquitin-dependent proteasome system. Genome-wide knockdown or knockout screens, together with transcriptomic and proteomic analyses conducted in both mosquito and mammalian cells, revealed the involvement of various components of the UPS in Flavivirus infection82 (Fig. 3B). For example, components of the ERAD pathway were identified in a recent CRISPR–Cas9 knockout screen as essential factors for several flaviviruses48. For DENV infection, upregulation of UPS-related genes has been observed in both infected cell lines and peripheral blood mononuclear cells derived from infected individuals, arguing for the physiological relevance of the UPS in Flavivirus infection83. Moreover, the UPS or components thereof are required for efficient virus production in the mosquito midgut84, which is consistent with quantitative proteomic analyses of mosquito cells infected with ZIKV that show increased UPS protein levels85. Proteasome inhibitors MG132 and bortezomib exert antiviral activity against ZIKV and DENV in vitro and reduce viral load in an in vivo mouse model85,86. Collectively, these data indicate that both early and late events in the Flavivirus replication cycle require components of the UPS84,86,87,88. Although a strong dependence on the UPS was not observed for HCV infection48,89, several UPS components are required for efficient viral replication90. Interestingly, UPS components of relevance for HCV replication are also required for WNV and DENV replication90, suggesting an evolutionarily conserved role in the replication cycles of members of Flaviviridae.
UPS-mediated viral protein degradation can also restrict viral replication and enhance an adaptive antiviral immune response by increasing the presentation of antigenic peptides to cytotoxic T cells. By contrast, HCV exploits UPS-mediated protein degradation to alter the stoichiometry of viral proteins. For instance, it has been reported that the viral NS5B RNA-dependent RNA polymerase is rapidly degraded to prevent possible interference with genome packaging91. The proteasome also regulates HCV core stability via ubiquitin-dependent and ubiquitin-independent mechanisms, thus restricting or enhancing HCV particle production, respectively. Finally, all Flaviviridae family members induce proteasomal degradation of specific restriction factors as well as innate signalling components such as signal transducer and activator of transcription 2 (STAT2) (in the case of DENV and ZIKV) or signal transducer and activator of transcription 1 and 3 (STAT1 and STAT3, respectively) (in the case of HCV)92,93,94,95,96,97,98,99 (Fig. 3B).
Autophagy. Autophagy is a catabolic process involving the formation of DMVs (autophagosomes) that engulf cytoplasmic content, cellular organelles, protein aggregates and pathogens for lysosomal degradation. Increased formation of autophagosomes and modulation of the autophagic flux has been consistently observed in DENV, ZIKV and HCV-infected cells100,101 (Fig. 3B). For flaviviruses, autophagy induction is mediated by NS4A for DENV and NS4A in addition to NS4B for ZIKV102,103,104 (Fig. 3B). In contrast to DENV, where NS4A-induced autophagy confers protection from cell death, ZIKV proteins dysregulate autophagy through AKT1–mTOR (RAC-α serine/threonine-protein kinase–mechanistic target of rapamycin) inhibition, leading to increased cell death and altered neurogenesis in fetal neural stem cells. For DENV, infectious vesicles containing viral RNA and autophagy markers were detected in supernatants of infected cells and in patient sera, supporting a role for autophagy as an alternative viral transmission route105. For both flaviviruses and HCV, viral proteins and RNA were found to colocalize with autophagosomes, suggesting that viral ROs associate with autophagic membranes106,107. Whereas the ER origin of flavivirus ROs refutes this hypothesis, an involvement of autophagic factors in the formation of the HCV-induced membranous web was recently reported9,108. This study showed that the autophagosome membrane elongation complex ATG5–ATG12–ATG16L1 was recruited to the membranous web, potentially through an interaction between ATG5 and NS4B (Refs 108,109) (Fig. 3B). Knockdown of either ubiquitin-like modifier-activating enzyme ATG7 or ubiquitin-like protein ATG12 expression produced aberrant membranous web structures and reduced viral replication, suggesting that this complex contributes to the formation of HCV ROs. For HCV, autophagy has been suggested to function during the early stages of virus infection, such as translation of incoming HCV RNA or formation of the membranous web110,111. Additionally, recent reports indicate roles for autophagy in HCV particle secretion and the release of exosomes, which contain viral RNA fragments and infectious full-length HCV genomes112,113.
In addition to general autophagy, several selective autophagy pathways are targeted during viral replication. DENV infection alters mTOR signalling to activate lipophagy, whereas both DENV and ZIKV inhibit ER-phagy through viral protease-dependent cleavage of the ER-phagy receptor reticulophagy regulator 1 (FAM134B114,115,116,117; also known as RETREG1) (Fig. 3B). By contrast, HCV induces mitophagy to attenuate virus-induced apoptosis and, consistent with these observations, inhibition of mitophagy by knockdown of parkin impairs HCV replication118. To summarize, autophagy has mostly been attributed to a proviral function in HCV, DENV and ZIKV replication cycles; however, further studies are required to better characterize the molecular mechanisms of autophagy–virus interactions.
Lipids and lipid metabolism
Flaviviridae replication occurs in strict association with cellular membranes, and members within this virus family have developed the ability to modify the lipid composition of membranes at replication and assembly sites (reviewed in Refs 119,120). These lipid alterations presumably change the physical properties of membranes, such as permeability, fluidity and bending capacity. Several studies highlight the importance of lipid biosynthetic pathways in Flavivirus and Hepacivirus replication (Fig. 3C). For instance, DENV, WNV and HCV replication is highly sensitive to depletion or pharmacological inhibition of acetyl-CoA carboxylase and fatty acid synthase (FASN)120,121, which are key enzymes in the fatty acid biosynthetic pathway. Indeed, DENV NS3 and HCV NS5B proteins were shown to interact with FASN and mediate its recruitment to the vicinity of viral replication sites, where it likely promotes the local synthesis of fatty acids that are required for efficient virus replication or, alternatively, enhances the catalytic activity of the NS5B polymerase in the case of HCV119. In addition to fatty acids, cholesterol biosynthesis also appears to be required for Flaviviridae virus replication. Inhibitors of the 3-hydroxy-3-methylglutaryl-CoA reductase (HMGCR), a rate-limiting enzyme in the cholesterol biosynthetic mevalonate pathway, decreases DENV replication in primary human monocytes and cultured cell lines120. It was observed that DENV infection increases the activity of HMGCR through the inactivation of 5′ AMP-activated protein kinase (AMPK), resulting in higher levels of cholesterol in the ER and increased viral replication122 (Fig. 3C). Consistent with this, treatment with AMPK inhibitors was shown to exert a proviral effect. However, a recent report suggests that DENV infection transiently stimulates AMPK phosphorylation, leading to the inactiation of mTOR complex 1 (mTORC1) and induction of lipophagy117. In this study, pharmacological inhibition of AMPK was found to be antiviral. The reasons behind these conflicting results are currently unknown but may relate to the experimental conditions that were used or a cell type-dependent effect.
For HCV, virus infection or ectopic expression of core protein or NS4B was able to induce the proteolytic activation of transcription factors belonging to the sterol regulatory element-binding protein (SREBP) pathway and increase the level of FASN, HMGCR and other lipogenic transcripts119. Additionally, the ATP-dependent RNA helicase DDX3X interacts with the HCV 3′ UTR and activates the innate immunity regulator inhibitor of nuclear factor-κB kinase subunit-α (IKKα), which in turn induces the expression of SREBP through CREB-binding protein–histone acetyltransferase p300 (CBP–p300)-dependent gene induction119,123 (Fig. 3C). Alterations in the lipid profile of infected cells were also uncovered by high-resolution mass spectrometry analysis of DENV, WNV or HCV-infected cells124,125,126. These studies revealed that changes in the lipid composition were especially pronounced in membrane fractions that were enriched in viral ROs, where the content of phospholipids, glycerophospholipids and sphingolipids (mainly ceramide) was increased124,125,126. Interestingly, although DENV and HCV promote an overall increase in cellular phosphatidylcholine content, only HCV seems to induce the accumulation of this lipid in the perinuclear ER membrane where NS5A is present124,126,127. In addition, purification of HCV DMVs revealed cholesterol enrichment, which is otherwise present at low levels in the ER of uninfected cells18. It was found that different cholesterol transport proteins, such as the oxysterol-binding protein (OSBP) and the Niemann–Pick C1 protein (NPC1), participate in this cholesterol enrichment and are selectively exploited by HCV but not DENV128,129. Overall, these findings support the concept that hepaciviruses and flaviviruses alter the local lipid composition of the ER to promote their replication.
A remarkable example of the importance of the generation of specialized membrane microenvironments during virus replication is the activation of phosphatidylinositol 4-kinase-α (PI4KA) by HCV NS5A, which results in the local enrichment of phosphatidylinositol-4-phosphate (PtdIns4P)35,130. Reduction of PtdIns4P levels, either through gene PI4KA silencing or pharmacological inhibition, results in the formation of smaller and aggregated DMVs and a consequent reduction in virus replication35. PtdIns4P is required to promote the accumulation of cholesterol at viral replication sites through a non-vesicular cholesterol transport mechanism involving OSBP128 (Fig. 3C, inset). Importantly, PtdIns4P and OSBP activity are required for the formation of the HCV membranous web but are dispensable for DENV replication, highlighting differences between the two virus genera35,128. In the case of HCV, it has been shown that PI4Kα is recruited by NS5A and NS5B to DMVs, where the kinase is activated to produce high amounts of PtdIns4P locally. It is assumed that PtdIns4P is used to facilitate the release of cholesterol from OSBP, which is discharged from the protein in exchange for PtdIns4P (reviewed in Ref. 8). A similar mechanism might operate for the enrichment of glycosphingolipids in DMV membranes via pleckstrin homology domain-containing family A member 8 (FAPP2)131 (Fig. 3C).
Utilization of organelles and networks
The utilization or manipulation of cellular organelles and molecular networks of relevance for cellular homeostasis by viruses must tread a fine line between promoting virus propagation and maintaining cell survival. This also applies to Flaviviridae members that exploit cytoskeletal, mitochondrial or nucleocytoplasmic transport networks (Fig. 4).
a | Flaviviridae viruses alter mitochondrial morphodynamics, leading to mitochondrial elongation in the case of dengue virus (DENV) or mitochondrial fragmentation in the case of hepatitis C virus (HCV), through the manipulation of specific mitochondrial fission and fusion proteins. b | HCV infection increases the intracellular levels of septin 9 and phosphatidylinositol 5-phosphate (PtdIns5P). The septin 9 interaction with PtdIns5P modulates lipid droplet growth and recruitment to the perinuclear area in a microtubule-dependent manner, thus creating an environment that favours viral replication. HCV proteins also recruit components of the nuclear transport machinery to regions of viral replication and assembly. c | DENV and ZIKV infection causes the rearrangement of microtubules and intermediate filaments surrounding replication organelles and leads to nuclear distortion in the case of ZIKV infection. d | Several Flaviviridae virus proteins contain nuclear localization and nuclear export signal sequences and are recruited to the nuclear compartment in infected cells. However, the dynamics of nuclear import and/or export as well as the specific function of these proteins within the nuclear compartment are not clear. HCV and Japanese encephalitis virus (JEV) impair nuclear import of immune transcription factors to limit immune activation in infected cells. DRP1, dynamin 1-like protein; IRF3, interferon regulatory factor 3; KAP, keratin-associated protein; MAM, mitochondrial-associated membrane; NS, non-structural; NF-κB, nuclear factor-κB; NUP, nuclear pore complex protein.
Cytoskeleton
The cytoskeleton has been reported to function at several stages of the replication cycle for members of the Flaviviridae family. For DENV infection, entry into host cells depends on microfilament integrity132,133. Additionally, the formation of viral ROs causes substantial remodelling of the intracellular endomembrane system and concomitantly alters the cytoskeletal architecture. DENV and ZIKV rearrange the cytoskeleton to form a cage-like structure that surrounds viral ROs (Fig. 4c). In the case of DENV, the reorganization of the intermediate filament vimentin has been observed, which is thought to arise through interactions with NS4A134. Moreover, treatment of infected cells with drugs that disrupt intermediate filaments also inhibits viral replication135. In ZIKV-infected cells, nuclei are distorted to accommodate the perinuclear accumulation of viral ROs, which are surrounded by thick bundles of intermediate filaments and microtubules. Treatment with paclitaxel, a microtubule-stabilizing drug, has a strong antiviral effect, suggesting that microtubule flexibility is required for efficient ZIKV infection10.
For HCV, microtubules are required for both the entry and post-entry steps of viral infection136. Inhibition of actin and microtubule polymerization decreases viral RNA levels in HCV-infected cells, suggesting a role for these structures in translation or viral genome amplification137. Recently, a role for septins in HCV replication has been suggested. For instance, septin 9 interacts with microtubules and PtdIns5P to modulate lipid droplet growth and subcellular localization, creating a lipid-enriched environment that is favourable for HCV replication138 (Fig. 4). Thus, the role of the cytoskeleton may extend beyond viral entry and contribute to the biogenesis and maintenance of viral ROs.
Nucleocytoplasmic transport machinery
The nuclear pore complex (NPC) mediates macromolecular transport between the cytoplasm and the nucleus and, as such, the NPC and the associated transport machinery have important roles in regulating many cellular pathways. Viruses have evolved ways to utilize or bypass the NPC or nucleocytoplasmic transport machinery in order to manipulate the host cell environment and facilitate viral propagation (reviewed in Ref. 139). In the case of Flaviviridae family members, many viral proteins are reported to interact with components of the nuclear transport machinery in order to gain access to the nucleus or to disrupt nucleocytoplasmic transport (Fig. 4). For instance, the DENV capsid and NS5 proteins contain nuclear localization signal (NLS) sequences and localize to the nucleus140. Though the majority of ZIKV and DENV NS5 protein is observed in the nucleus, there is no nuclear function currently associated with these proteins, and the disruption of this nuclear localization does not strictly correlate with changes in DENV replication in vitro141,142.
Several HCV proteins, including core protein, NS2, NS3 and NS5, also contain NLS sequences and have been reported to interact with components of the nuclear transport machinery (reviewed in Ref. 143) (Fig. 4d). However, unlike DENV capsid and NS5, in HCV-infected cells, substantial levels of viral protein accumulation in the nucleus have not been observed. Two roles for these NLS sequences have been proposed. First, several reports have suggested that nuclear NS5A and core protein directly or indirectly alter host transcriptional activation. Second, recent reports have proposed that the nuclear transport machinery has a cytoplasmic role in protecting HCV RNA from being sensed by PRRs. These reports suggest that HCV recruits components of the NPC and nuclear transport machinery to viral ROs to create a selective barrier between the cytosol and the interior of ROs, thus effectively blocking immune activation while still allowing access to molecules that are required for viral replication21,22,144.
Selective trafficking of molecules, especially viral genomes and metabolites, between the cytosolic and the membrane compartments of ROs, as well as passive immune evasion through shielding of replication intermediates, has been proposed for other (+)RNA viruses, including DENV and TBEV21,22,145. These results suggest that cellular transport molecules may be involved in chaperoning or transporting viral genomic material between specific cellular compartments, substantially impacting the spatio-temporal organization of viral ROs. Components of the nucleocytoplasmic transport machinery have also been found in HCV particles, suggesting that these proteins have a structural role in virus assembly146. Moreover, recent reports have demonstrated that both HCV and JEV interfere with the nuclear translocation of interferon regulatory factor 3 (IRF3) and nuclear factor-κB (NF-κB), thereby attenuating innate immune activation147,148 (Fig. 4d). Thus, the NPC and associated transport factors represent a central host network that is a strategic target for Flaviviridae infection.
Mitochondria
Mitochondria and MAMs are also convergent sites for cellular processes that are important for viral infection, including ATP synthesis, lipid biogenesis and export, PRR-mediated immune activation and apoptosis initiation. Flaviviridae family members interact with mitochondria and MAMs to either potentiate or mitigate these mitochondria-associated processes13,149,150. Reports on the impact of flaviviruses, particularly DENV, on mitochondrial structure and function are still somewhat contradictory. Two recent studies demonstrate that DENV or ZIKV infection antagonizes dynamin 1-like protein (DRP1) function, leading to mitochondrial elongation and a reduction in MAMs, which favours viral replication14,151. This virus-induced mitochondrial elongation enhances respiration to increase virus replication, and the sequestration of MAMs in virus-induced CMs appears to contribute to attenuating innate immune activation (Fig. 4). Moreover, the expression of DENV NS4B is sufficient to induce mitochondrial elongation. In contrast to these findings, two other studies have reported DENV-induced mitochondrial fragmentation that is mediated by mitofusin degradation152,153. These studies suggest a mechanism similar to HCV in which virus-induced mitochondrial fission inhibits apoptosis and alleviates immune activation118,154. The differences between these reported observations could arise from differences in experimental setup or host cells that were used for infection. However, in both cases, it is clear that mitochondrial morphodynamics have an important role in Flavivirus infection.
In the case of HCV, viral proteins are enriched on mitochondria and MAMs, and viral infection promotes mitochondrial fragmentation and mitophagy118,154,155 (Fig. 4). Additionally, reports have described MAMs as the sites of either viral RNA replication or assembly, further demonstrating the close association between HCV and mitochondria. The mitochondria and MAMs are also important for immune signalling, and both DENV and HCV have been suggested to disrupt the mitochondrial network in order to avoid immune activation.
Conclusions
Virus replication requires sophisticated manipulation of cellular pathways to maintain a balance between host cell survival and efficient virus replication. In the case of the Flaviviridae, virus infection leads to a substantial rearrangement of host cell structures and alterations in many pathways, creating an environment that is permissive to virus propagation. Considerable advances have been made in this area that have provided new and important insights into various aspects of the cell biology of virus infection, such as the discovery of a novel pathway to induce the expression of genes that are required for lipid biosynthesis119,123, the identification of new protein folds as illustrated by the three-dimensional structure of DENV NS127 or novel insights into the mechanisms underlying virus-induced neuropathogenesis7. Moreover, comparative analyses of flaviviruses and hepaciviruses as reviewed here will help us to understand the evolutionary relationship between virus genera. For instance, the biogenesis and three-dimensional structures of the membranous ROs of flaviviruses are more similar to those of alphaviruses and nodaviruses, whereas the ROs of HCV resemble more those of picornaviruses and coronaviruses (reviewed in Ref. 156). This probably reflects the differential use of distinct lipid synthesis and transfer pathways, which offers an interesting yet challenging alternative for the analysis of virus evolution that so far is primarily based on algorithms comparing nucleotide or amino acid sequence similarities.
High-content screening projects have led to the identification of several host cell pathways and individual factors as promising targets for broad-spectrum antivirals, such as the signal peptidase complex44, the OST complex48 and the host cell chaperone network50,52 as well as others68,157,158. Although studies in more physiologically relevant systems are required to demonstrate the suitability of these targets for therapeutic approaches, the results per se have revealed surprising new insights into the cell biology of these cellular machines. For instance, an individual subunit of the signal peptidase complex can be eliminated without overt cytotoxicity in vitro while blocking virus replication, arguing that an approach that targets this subunit could have strong antiviral effects with low cytotoxicity44. In light of these results, we can expect that additional fundamental discoveries in cell biology will continue to be made while enhancing our understanding of virus replication and pathogenesis. This knowledge may provide insights into how the balance could be tipped in a direction that promotes the activation of pathways that are aimed at limiting virus replication or spread, with the ultimate goal of developing broad-spectrum antivirals.
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Reviewer information
Nature Reviews Microbiology thanks S. Bradrick and M. Garcia-Blanco, B. Lindenbach, G. Randall and C. Rice for their contributions to the peer review of this work.
References
[No authors listed.] Taxonomy. International Committee on Taxonomy of Viruses (ICTV) https://talk.ictvonline.org/taxonomy/ (2017).
[No authors listed.] Hepatitis C fact sheet. World Health Organization http://www.who.int/mediacentre/factsheets/fs164/en/ (2017).
Manns, M. P. et al. Hepatitis C virus infection. Nat. Rev. Dis. Primers. 3, 17006 (2017).
Stanaway, J. D. et al. The global burden of dengue: an analysis from the Global Burden of Disease Study 2013. Lancet Infect. Dis. 16, 712–723 (2016).
Hadinegoro, S. R. et al. Efficacy and long-term safety of a dengue vaccine in regions of endemic disease. N. Engl. J. Med. 373, 1195–1206 (2015).
Wikan, N. & Smith, D. R. Zika virus: history of a newly emerging arbovirus. Lancet Infect. Dis. 16, e119–e126 (2016).
Miner, J. J. & Diamond, M. S. Zika virus pathogenesis and tissue tropism. Cell Host Microbe 21, 134–142 (2017).
Paul, D. & Bartenschlager, R. Flaviviridae replication organelles: oh, what a tangled web we weave. Annu. Rev. Virol. 2, 289–310 (2015).
Welsch, S. et al. Composition and three-dimensional architecture of the dengue virus replication and assembly sites. Cell Host Microbe 5, 365–375 (2009). This study reveals the three-dimensional architecture of DENV ROs using electron tomography. This study also identifies assembling virus particles in close apposition of viral replication sites and provides a model on the spatio-temporal coupling of the different steps of the DENV life cycle.
Cortese, M. et al. Ultrastructural characterization of Zika virus replication factories. Cell Rep. 18, 2113–2123 (2017).
Gillespie, L. K., Hoenen, A., Morgan, G. & Mackenzie, J. M. The endoplasmic reticulum provides the membrane platform for biogenesis of the flavivirus replication complex. J. Virol. 84, 10438–10447 (2010).
Westaway, E. G., Mackenzie, J. M., Kenney, M. T., Jones, M. K. & Khromykh, A. A. Ultrastructure of Kunjin virus-infected cells: colocalization of NS1 and NS3 with double-stranded RNA, and of NS2B with NS3, in virus-induced membrane structures. J. Virol. 71, 6650–6661 (1997).
Horner, S. M., Liu, H. M., Park, H. S., Briley, J. & Gale, M. Jr. Mitochondrial-associated endoplasmic reticulum membranes (MAM) form innate immune synapses and are targeted by hepatitis C virus. Proc. Natl Acad. Sci. USA 108, 14590–14595 (2011).
Chatel-Chaix, L. et al. Dengue virus perturbs mitochondrial morphodynamics to dampen innate immune responses. Cell Host Microbe 20, 342–356 (2016).
Junjhon, J. et al. Ultrastructural characterization and three-dimensional architecture of replication sites in dengue virus-infected mosquito cells. J. Virol. 88, 4687–4697 (2014).
Romero-Brey, I. et al. Three-dimensional architecture and biogenesis of membrane structures associated with hepatitis C virus replication. PLOS Pathog. 8, e1003056 (2012). This study uses electron tomography to reveal that HCV ROs are primarily composed of double-membrane vesicles and provides evidence that these structures might be the site of viral RNA replication.
Esser-Nobis, K. et al. Analysis of hepatitis C virus resistance to silibinin in vitro and in vivo points to a novel mechanism involving nonstructural protein 4B. Hepatology 57, 953–963 (2013).
Paul, D., Hoppe, S., Saher, G., Krijnse-Locker, J. & Bartenschlager, R. Morphological and biochemical characterization of the membranous hepatitis C virus replication compartment. J. Virol. 87, 10612–10627 (2013).
Quinkert, D., Bartenschlager, R. & Lohmann, V. Quantitative analysis of the hepatitis C virus replication complex. J. Virol. 79, 13594–13605 (2005).
Miyanari, Y. et al. Hepatitis C virus non-structural proteins in the probable membranous compartment function in viral genome replication. J. Biol. Chem. 278, 50301–50308 (2003).
Neufeldt, C. J. et al. The hepatitis C virus-induced membranous web and associated nuclear transport machinery limit access of pattern recognition receptors to viral replication sites. PLOS Pathog. 12, e1005428 (2016).
Neufeldt, C. J. et al. Hepatitis C virus-induced cytoplasmic organelles use the nuclear transport machinery to establish an environment conducive to virus replication. PLOS Pathog. 9, e1003744 (2013).
Zou, J. et al. Dimerization of flavivirus NS4B protein. J. Virol. 88, 3379–3391 (2014).
Spuul, P. et al. Assembly of alphavirus replication complexes from RNA and protein components in a novel trans-replication system in mammalian cells. J. Virol. 85, 4739–4751 (2011).
Kallio, K., Hellstrom, K., Jokitalo, E. & Ahola, T. RNA replication and membrane modification require the same functions of alphavirus nonstructural proteins. J. Virol. 90, 1687–1692 (2015).
Ertel, K. J. et al. Cryo-electron tomography reveals novel features of a viral RNA replication compartment. eLife 6, e25940 (2017).
Akey, D. L. et al. Flavivirus NS1 structures reveal surfaces for associations with membranes and the immune system. Science 343, 881–885 (2014). This study is the first report of the three-dimensional structure of full-length, glycosylated NS1 from WNV and DENV, revealing distinct domains for membrane association of the dimer and interactions with the immune system.
Brown, W. C. et al. Extended surface for membrane association in Zika virus NS1 structure. Nat. Struct. Mol. Biol. 23, 865–867 (2016).
Apte-Sengupta, S., Sirohi, D. & Kuhn, R. J. Coupling of replication and assembly in flaviviruses. Curr. Opin. Virol. 9, 134–142 (2014).
Tabata, K. et al. Unique requirement for ESCRT factors in flavivirus particle formation on the endoplasmic reticulum. Cell Rep. 16, 2339–2347 (2016).
Romero-Brey, I. et al. NS5A domain 1 and polyprotein cleavage kinetics are critical for induction of double-membrane vesicles associated with hepatitis C virus replication. mBio 6, e00759 (2015).
Egger, D. et al. Expression of hepatitis C virus proteins induces distinct membrane alterations including a candidate viral replication complex. J. Virol. 76, 5974–5984 (2002).
Paul, D. et al. NS4B self-interaction through conserved C-terminal elements is required for the establishment of functional hepatitis C virus replication complexes. J. Virol. 85, 6963–6976 (2011).
Madan, V., Paul, D., Lohmann, V. & Bartenschlager, R. Inhibition of HCV replication by cyclophilin antagonists is linked to replication fitness and occurs by inhibition of membranous web formation. Gastroenterology 146, 1361–1372.e9 (2014).
Reiss, S. et al. Recruitment and activation of a lipid kinase by hepatitis C virus NS5A is essential for integrity of the membranous replication compartment. Cell Host Microbe 9, 32–45 (2011).
Moradpour, D. & Penin, F. Hepatitis C virus proteins: from structure to function. Curr. Top. Microbiol. Immunol. 369, 113–142 (2013).
Berger, C. et al. Daclatasvir-like inhibitors of NS5A block early biogenesis of hepatitis C virus-induced membranous replication factories, independent of RNA replication. Gastroenterology 147, 1094–1105.e25 (2014).
Acosta, E. G., Kumar, A. & Bartenschlager, R. Revisiting dengue virus-host cell interaction: new insights into molecular and cellular virology. Adv. Virus Res. 88, 1–109 (2014).
Bartenschlager, R., Lohmann, V. & Penin, F. The molecular and structural basis of advanced antiviral therapy for hepatitis C virus infection. Nat. Rev. Microbiol. 11, 482–496 (2013).
Stocks, C. E. & Lobigs, M. Signal peptidase cleavage at the flavivirus C-prM junction: dependence on the viral NS2B-3 protease for efficient processing requires determinants in C, the signal peptide, and prM. J. Virol. 72, 2141–2149 (1998).
Amberg, S. M. & Rice, C. M. Mutagenesis of the NS2B-NS3-mediated cleavage site in the flavivirus capsid protein demonstrates a requirement for coordinated processing. J. Virol. 73, 8083–8094 (1999).
Lee, E., Stocks, C. E., Amberg, S. M., Rice, C. M. & Lobigs, M. Mutagenesis of the signal sequence of yellow fever virus prM protein: enhancement of signalase cleavage in vitro is lethal for virus production. J. Virol. 74, 24–32 (2000).
Lobigs, M. & Lee, E. Inefficient signalase cleavage promotes efficient nucleocapsid incorporation into budding flavivirus membranes. J. Virol. 78, 178–186 (2004).
Zhang, R. et al. A CRISPR screen defines a signal peptide processing pathway required by flaviviruses. Nature 535, 164–168 (2016). This genome-wide CRISPR–Cas9-based screen to identify host dependency factors for the Flaviviridae life cycle reveals a strong dependence on the signal peptide processing pathway for the replication of this virus family.
Estoppey, D. et al. The natural product cavinafungin selectively interferes with Zika and dengue virus replication by inhibition of the host signal peptidase. Cell Rep. 19, 451–460 (2017).
Idris, F., Muharram, S. H. & Diah, S. Glycosylation of dengue virus glycoproteins and their interactions with carbohydrate receptors: possible targets for antiviral therapy. Arch. Virol. 161, 1751–1760 (2016).
Hundt, J., Li, Z. & Liu, Q. Post-translational modifications of hepatitis C viral proteins and their biological significance. World J. Gastroenterol. 19, 8929–8939 (2013).
Marceau, C. D. et al. Genetic dissection of Flaviviridae host factors through genome-scale CRISPR screens. Nature 535, 159–163 (2016). This is a genome-wide CRISPR–Cas9-based screen that is used to identify host dependency factors for Flaviviridae virus infection and reveals a non-canonical role for the OST complex in DENV RNA replication.
Lin, D. L. et al. Dengue virus hijacks a noncanonical oxidoreductase function of a cellular oligosaccharyltransferase complex. mBio 8, e00939-17 (2017).
Taguwa, S. et al. Defining Hsp70 subnetworks in dengue virus replication reveals key vulnerability in Flavivirus infection. Cell 163, 1108–1123 (2015). This is a comprehensive study examining the role of HSP70 and its specific co-chaperones for Flavivirus replication. Specifically, this study demonstrates a conserved role of the HSP70 network for all stages of the Flavivirus replication cycle.
Taguwa, S. & Frydman, J. The significance of Hsp70 subnetwork for dengue virus lifecycle. Uirusu 65, 179–186 (2015).
Yi, Z. et al. Identification and characterization of the host protein DNAJC14 as a broadly active flavivirus replication modulator. PLOS Pathog. 7, e1001255 (2011).
Bozzacco, L. et al. Chaperone-assisted protein folding is critical for yellow fever virus NS3/4A cleavage and replication. J. Virol. 90, 3212–3228 (2016).
Gonzalez, O. et al. The heat shock protein inhibitor Quercetin attenuates hepatitis C virus production. Hepatology 50, 1756–1764 (2009).
Peng, Z. G. et al. Small molecular compounds that inhibit hepatitis C virus replication through destabilizing heat shock cognate 70 messenger RNA. Hepatology 52, 845–853 (2010).
Khachatoorian, R. et al. Allosteric heat shock protein 70 inhibitors block hepatitis C virus assembly. Int. J. Antimicrob. Agents 47, 289–296 (2016).
Khachatoorian, R. et al. The NS5A-binding heat shock proteins HSC70 and HSP70 play distinct roles in the hepatitis C viral life cycle. Virology 454–455, 118–127 (2014).
Braga, A. C., Carneiro, B. M., Batista, M. N., Akinaga, M. M. & Rahal, P. Inhibition of hepatitis C virus using siRNA targeted to the virus and Hsp90. Cell Stress Chaperones 22, 113–122 (2017).
Baugh, J. M., Garcia-Rivera, J. A. & Gallay, P. A. Host-targeting agents in the treatment of hepatitis C: a beginning and an end? Antiviral Res. 100, 555–561 (2013).
Jheng, J. R., Ho, J. Y. & Horng, J. T. ER stress, autophagy, and RNA viruses. Front. Microbiol. 5, 388 (2014).
Diwaker, D., Mishra, K. P. & Ganju, L. Effect of modulation of unfolded protein response pathway on dengue virus infection. Acta Biochim. Biophys. Sin. 47, 960–968 (2015).
Smith, J. A. A new paradigm: innate immune sensing of viruses via the unfolded protein response. Front. Microbiol. 5, 222 (2014).
Salazar, M. et al. Cannabinoid action induces autophagy-mediated cell death through stimulation of ER stress in human glioma cells. J. Clin. Invest. 119, 1359–1372 (2009).
Bernales, S., McDonald, K. L. & Walter, P. Autophagy counterbalances endoplasmic reticulum expansion during the unfolded protein response. PLOS Biol. 4, e423 (2006).
Ogata, M. et al. Autophagy is activated for cell survival after endoplasmic reticulum stress. Mol. Cell. Biol. 26, 9220–9231 (2006).
Yorimitsu, T., Nair, U., Yang, Z. & Klionsky, D. J. Endoplasmic reticulum stress triggers autophagy. J. Biol. Chem. 281, 30299–30304 (2006).
Kedersha, N. L., Gupta, M., Li, W., Miller, I. & Anderson, P. RNA-binding proteins TIA-1 and TIAR link the phosphorylation of eIF-2 alpha to the assembly of mammalian stress granules. J. Cell Biol. 147, 1431–1442 (1999).
Sessions, O. M. et al. Discovery of insect and human dengue virus host factors. Nature 458, 1047–1050 (2009).
Chan, S. W. Unfolded protein response in hepatitis C virus infection. Front. Microbiol. 5, 233 (2014).
Perera, N., Miller, J. L. & Zitzmann, N. The role of the unfolded protein response in dengue virus pathogenesis. Cell. Microbiol. 19, e12734 (2017).
Pena, J. & Harris, E. Dengue virus modulates the unfolded protein response in a time-dependent manner. J. Biol. Chem. 286, 14226–14236 (2011).
Roth, H. et al. Flavivirus infection uncouples translation suppression from cellular stress responses. mBio 8, e02150-16 (2017).
Ruggieri, A. et al. Dynamic oscillation of translation and stress granule formation mark the cellular response to virus infection. Cell Host Microbe 12, 71–85 (2012). This is an elegant study that reveals the dynamics of stress granule assembly and disassembly and the role of this dynamic in counteracting RNA translation repression and prolonging cell survival.
Edgil, D., Polacek, C. & Harris, E. Dengue virus utilizes a novel strategy for translation initiation when cap-dependent translation is inhibited. J. Virol. 80, 2976–2986 (2006).
Khawaja, A., Vopalensky, V. & Pospisek, M. Understanding the potential of hepatitis C virus internal ribosome entry site domains to modulate translation initiation via their structure and function. Wiley Interdiscip. Rev. RNA 6, 211–224 (2015).
Walsh, D. & Mohr, I. Viral subversion of the host protein synthesis machinery. Nat. Rev. Microbiol. 9, 860–875 (2011).
Brewer, J. W. & Jackowski, S. UPR-mediated membrane biogenesis in B cells. Biochem. Res. Int. 2012, 738471 (2012).
Yoshida, H. et al. A time-dependent phase shift in the mammalian unfolded protein response. Dev. Cell 4, 265–271 (2003).
Ke, P. Y. & Chen, S. S. Activation of the unfolded protein response and autophagy after hepatitis C virus infection suppresses innate antiviral immunity in vitro. J. Clin. Invest. 121, 37–56 (2011).
Wang, J. et al. Hepatitis C virus core protein activates autophagy through EIF2AK3 and ATF6 UPR pathway-mediated MAP1LC3B and ATG12 expression. Autophagy 10, 766–784 (2014).
Yoshida, H., Matsui, T., Yamamoto, A., Okada, T. & Mori, K. XBP1 mRNA is induced by ATF6 and spliced by IRE1 in response to ER stress to produce a highly active transcription factor. Cell 107, 881–891 (2001).
Viktorovskaya, O. V., Greco, T. M., Cristea, I. M. & Thompson, S. R. Identification of RNA binding proteins associated with dengue virus RNA in infected cells reveals temporally distinct host factor requirements. PLOS Negl. Trop. Dis. 10, e0004921 (2016).
Fink, J. et al. Host gene expression profiling of dengue virus infection in cell lines and patients. PLOS Negl. Trop. Dis. 1, e86 (2007).
Choy, M. M., Sessions, O. M., Gubler, D. J. & Ooi, E. E. Production of infectious dengue virus in Aedes aegypti is dependent on the ubiquitin proteasome pathway. PLOS Negl. Trop. Dis. 9, e0004227 (2015).
Xin, Q. L. et al. Quantitative proteomic analysis of mosquito C6/36 cells reveals host proteins involved in Zika virus infection. J. Virol. 91, e00554-17 (2017).
Choy, M. M. et al. Proteasome inhibition suppresses dengue virus egress in antibody dependent infection. PLOS Negl. Trop. Dis. 9, e0004058 (2015).
Fernandez-Garcia, M. D. et al. Appraising the roles of CBLL1 and the ubiquitin/proteasome system for flavivirus entry and replication. J. Virol. 85, 2980–2989 (2011).
Byk, L. A. et al. Dengue virus genome uncoating requires ubiquitination. mBio 7, e00804-16 (2016).
Poenisch, M. et al. Identification of HNRNPK as regulator of hepatitis C virus particle production. PLOS Pathog. 11, e1004573 (2015).
Li, Q. et al. A genome-wide genetic screen for host factors required for hepatitis C virus propagation. Proc. Natl Acad. Sci. USA 106, 16410–16415 (2009).
Gao, L. et al. Interaction with a ubiquitin-like protein enhances the ubiquitination and degradation of hepatitis C virus RNA-dependent RNA polymerase. J. Virol. 77, 4149–4159 (2003).
Lin, W. et al. Hepatitis C virus expression suppresses interferon signaling by degrading STAT1. Gastroenterology 128, 1034–1041 (2005).
Lin, W. et al. Hepatitis C virus core protein blocks interferon signaling by interaction with the STAT1 SH2 domain. J. Virol. 80, 9226–9235 (2006).
Shao, R. X. et al. Suppressor of cytokine signaling 3 suppresses hepatitis C virus replication in an mTOR-dependent manner. J. Virol. 84, 6060–6069 (2010).
Zhang, X. et al. GP73 represses host innate immune response to promote virus replication by facilitating MAVS and TRAF6 degradation. PLOS Pathog. 13, e1006321 (2017).
Stevenson, N. J. et al. Hepatitis C virus targets the interferon-alpha JAK/STAT pathway by promoting proteasomal degradation in immune cells and hepatocytes. FEBS Lett. 587, 1571–1578 (2013).
Grant, A. et al. Zika virus targets human STAT2 to inhibit type I interferon signaling. Cell Host Microbe 19, 882–890 (2016).
Kumar, A. et al. Zika virus inhibits type-I interferon production and downstream signaling. EMBO Rep. 17, 1766–1775 (2016).
Ashour, J., Laurent-Rolle, M., Shi, P. Y. & Garcia-Sastre, A. NS5 of dengue virus mediates STAT2 binding and degradation. J. Virol. 83, 5408–5418 (2009).
Metz, P. et al. Dengue virus inhibition of autophagic flux and dependency of viral replication on proteasomal degradation of the autophagy receptor p62. J. Virol. 89, 8026–8041 (2015).
Wang, L., Tian, Y. & Ou, J. H. HCV induces the expression of Rubicon and UVRAG to temporally regulate the maturation of autophagosomes and viral replication. PLOS Pathog. 11, e1004764 (2015).
McLean, J. E., Wudzinska, A., Datan, E., Quaglino, D. & Zakeri, Z. Flavivirus NS4A-induced autophagy protects cells against death and enhances virus replication. J. Biol. Chem. 286, 22147–22159 (2011).
Datan, E. et al. Dengue-induced autophagy, virus replication and protection from cell death require ER stress (PERK) pathway activation. Cell Death Dis. 7, e2127 (2016).
Liang, Q. et al. Zika virus NS4A and NS4B proteins deregulate Akt-mTOR signaling in human fetal neural stem cells to inhibit neurogenesis and induce autophagy. Cell Stem Cell 19, 663–671 (2016).
Wu, Y. W. et al. Autophagy-associated dengue vesicles promote viral transmission avoiding antibody neutralization. Sci. Rep. 6, 32243 (2016).
Panyasrivanit, M., Khakpoor, A., Wikan, N. & Smith, D. R. Co-localization of constituents of the dengue virus translation and replication machinery with amphisomes. J. Gen. Virol. 90, 448–456 (2009).
Sir, D. et al. Replication of hepatitis C virus RNA on autophagosomal membranes. J. Biol. Chem. 287, 18036–18043 (2012).
Fahmy, A. M. & Labonte, P. The autophagy elongation complex (ATG5-12/16L1) positively regulates HCV replication and is required for wild-type membranous web formation. Sci. Rep. 7, 40351 (2017).
Guevin, C. et al. Autophagy protein ATG5 interacts transiently with the hepatitis C virus RNA polymerase (NS5B) early during infection. Virology 405, 1–7 (2010).
Dreux, M., Gastaminza, P., Wieland, S. F. & Chisari, F. V. The autophagy machinery is required to initiate hepatitis C virus replication. Proc. Natl Acad. Sci. USA 106, 14046–14051 (2009).
Dreux, M. & Chisari, F. V. Autophagy proteins promote hepatitis C virus replication. Autophagy 5, 1224–1225 (2009).
Shrivastava, S. et al. Knockdown of autophagy inhibits infectious hepatitis C virus release by the exosomal pathway. J. Virol. 90, 1387–1396 (2015).
Tanida, I. et al. Knockdown of autophagy-related gene decreases the production of infectious hepatitis C virus particles. Autophagy 5, 937–945 (2009).
Lennemann, N. J. & Coyne, C. B. Dengue and Zika viruses subvert reticulophagy by NS2B3-mediated cleavage of FAM134B. Autophagy 13, 322–332 (2017).
Heaton, N. S. & Randall, G. Dengue virus-induced autophagy regulates lipid metabolism. Cell Host Microbe 8, 422–432 (2010).
Routhu, N. K. & Byrareddy, S. N. Host-virus interaction of ZIKA virus in modulating disease pathogenesis. J. Neuroimmune Pharmacol. 12, 219–232 (2017).
Jordan, T. X. & Randall, G. Dengue virus activates the AMP kinase-mTOR axis to stimulate a proviral lipophagy. J. Virol. 91, e02020-16 (2017).
Kim, S. J. et al. Hepatitis C virus triggers mitochondrial fission and attenuates apoptosis to promote viral persistence. Proc. Natl Acad. Sci. USA 111, 6413–6418 (2014).
Paul, D., Madan, V. & Bartenschlager, R. Hepatitis C virus RNA replication and assembly: living on the fat of the land. Cell Host. Microbe 16, 569–579 (2014).
Martin-Acebes, M. A., Vazquez-Calvo, A. & Saiz, J. C. Lipids and flaviviruses, present and future perspectives for the control of dengue, Zika, and West Nile viruses. Prog. Lipid Res. 64, 123–137 (2016).
Merino-Ramos, T. et al. Modification of the host cell lipid metabolism induced by hypolipidemic drugs targeting the acetyl coenzyme A carboxylase impairs West Nile virus replication. Antimicrob. Agents Chemother. 60, 307–315 (2015).
Soto-Acosta, R., Bautista-Carbajal, P., Cervantes-Salazar, M., Angel-Ambrocio, A. H. & Del Angel, R. M. DENV up-regulates the HMG-CoA reductase activity through the impairment of AMPK phosphorylation: a potential antiviral target. PLOS Pathog. 13, e1006257 (2017).
Li, Q., Pene, V., Krishnamurthy, S., Cha, H. & Liang, T. J. Hepatitis C virus infection activates an innate pathway involving IKK-alpha in lipogenesis and viral assembly. Nat. Med. 19, 722–729 (2013). This study reveals a novel function of the innate immunity regulator IKK α in the regulation of lipogenic genes. This mechanism is exploited by HCV to promote lipid droplet formation and the assembly of infectious virus particles.
Perera, R. et al. Dengue virus infection perturbs lipid homeostasis in infected mosquito cells. PLOS Pathog. 8, e1002584 (2012).
Martin-Acebes, M. A. et al. The composition of West Nile virus lipid envelope unveils a role of sphingolipid metabolism in flavivirus biogenesis. J. Virol. 88, 12041–12054 (2014).
Diamond, D. L. et al. Temporal proteome and lipidome profiles reveal hepatitis C virus-associated reprogramming of hepatocellular metabolism and bioenergetics. PLOS Pathog. 6, e1000719 (2010).
Zhang, J. et al. Positive-strand RNA viruses stimulate host phosphatidylcholine synthesis at viral replication sites. Proc. Natl Acad. Sci. USA 113, E1064–E1073 (2016).
Wang, H. et al. Oxysterol-binding protein is a phosphatidylinositol 4-kinase effector required for HCV replication membrane integrity and cholesterol trafficking. Gastroenterology 146, 1373–1385.e11 (2014). This study demonstrates that oxysterol-binding protein is recruited to the HCV membranous web in a phosphatidylinositol 4-kinase (PI4K)-dependent manner that is required to regulate cholesterol trafficking to HCV ROs.
Stoeck, I. K. et al. Hepatitis C virus replication depends on endosomal cholesterol homeostasis. J. Virol. 92, e01196–17 (2017).
Harak, C. et al. Mapping of functional domains of the lipid kinase phosphatidylinositol 4-kinase type III alpha involved in enzymatic activity and hepatitis C virus replication. J. Virol. 88, 9909–9926 (2014).
Khan, I. et al. Modulation of hepatitis C virus genome replication by glycosphingolipids and four-phosphate adaptor protein 2. J. Virol. 88, 12276–12295 (2014).
Zhang, J. et al. Small G Rac1 is involved in replication cycle of dengue serotype 2 virus in EAhy926 cells via the regulation of actin cytoskeleton. Sci. China Life Sci. 59, 487–494 (2016).
Zamudio-Meza, H., Castillo-Alvarez, A., Gonzalez-Bonilla, C. & Meza, I. Cross-talk between Rac1 and Cdc42 GTPases regulates formation of filopodia required for dengue virus type-2 entry into HMEC-1 cells. J. Gen. Virol. 90, 2902–2911 (2009).
Teo, C. S. & Chu, J. J. Cellular vimentin regulates construction of dengue virus replication complexes through interaction with NS4A protein. J. Virol. 88, 1897–1913 (2014).
Chen, W. et al. Vimentin is required for dengue virus serotype 2 infection but microtubules are not necessary for this process. Arch. Virol. 153, 1777–1781 (2008).
Roohvand, F. et al. Initiation of hepatitis C virus infection requires the dynamic microtubule network: role of the viral nucleocapsid protein. J. Biol. Chem. 284, 13778–13791 (2009).
Bost, A. G., Venable, D., Liu, L. & Heinz, B. A. Cytoskeletal requirements for hepatitis C virus (HCV) RNA synthesis in the HCV replicon cell culture system. J. Virol. 77, 4401–4408 (2003).
Akil, A. et al. Septin 9 induces lipid droplets growth by a phosphatidylinositol-5-phosphate and microtubule-dependent mechanism hijacked by HCV. Nat. Commun. 7, 12203 (2016). This study reports that septin 9 can modulate the growth of lipid droplets through microtubule-dependent and PtdIns5P-dependent mechanisms. Such an ability is exploited by HCV to create an environment favourable for its replication.
Mettenleiter, T. C. Breaching the barrier-the nuclear envelope in virus infection. J. Mol. Biol. 428, 1949–1961 (2016).
Byk, L. A. & Gamarnik, A. V. Properties and functions of the dengue virus capsid protein. Annu. Rev. Virol. 3, 263–281 (2016).
Kumar, A. et al. Nuclear localization of dengue virus nonstructural protein 5 does not strictly correlate with efficient viral RNA replication and inhibition of type I interferon signaling. J. Virol. 87, 4545–4557 (2013).
Hannemann, H. et al. Serotype-specific differences in dengue virus non-structural protein 5 nuclear localization. J. Biol. Chem. 288, 22621–22635 (2013).
Bonamassa, B. et al. Hepatitis C virus and host cell nuclear transport machinery: a clandestine affair. Front. Microbiol. 6, 619 (2015).
Levin, A. et al. Functional characterization of nuclear localization and export signals in hepatitis C virus proteins and their role in the membranous web. PLOS ONE 9, e114629 (2014).
Overby, A. K. & Weber, F. Hiding from intracellular pattern recognition receptors, a passive strategy of flavivirus immune evasion. Virulence 2, 238–240 (2011).
Lussignol, M. et al. Proteomics of HCV virions reveals an essential role for the nucleoporin Nup98 in virus morphogenesis. Proc. Natl Acad. Sci. USA 113, 2484–2489 (2016). This study determines the protein composition of HCV virions and identifies multiple cellular proteins, with nuclear pore complex protein NUP98 playing an important role in virus propagation.
Ye, J. et al. Japanese encephalitis virus NS5 inhibits type I interferon (IFN) production by blocking the nuclear translocation of IFN regulatory factor 3 and NF-kappaB. J. Virol. 91, e00039-17 (2017).
Gagne, B., Tremblay, N., Park, A. Y., Baril, M. & Lamarre, D. Importin beta1 targeting by hepatitis C virus NS3/4A protein restricts IRF3 and NF-kappaB signaling of IFNB1 antiviral response. Traffic 18, 362–377 (2017).
Miyanari, Y. et al. The lipid droplet is an important organelle for hepatitis C virus production. Nat. Cell Biol. 9, 1089–1097 (2007).
Vance, J. E. MAM (mitochondria-associated membranes) in mammalian cells: lipids and beyond. Biochim. Biophys. Acta 1841, 595–609 (2014).
Barbier, V., Lang, D., Valois, S., Rothman, A. L. & Medin, C. L. Dengue virus induces mitochondrial elongation through impairment of Drp1-triggered mitochondrial fission. Virology 500, 149–160 (2017).
Yu, C. Y. et al. Dengue virus impairs mitochondrial fusion by cleaving mitofusins. PLOS Pathog. 11, e1005350 (2015).
Aguirre, S. et al. Dengue virus NS2B protein targets cGAS for degradation and prevents mitochondrial DNA sensing during infection. Nat. Microbiol. 2, 17037 (2017). This is a study demonstrating a block of type I interferon activation through NS2B-mediated lysosomal degradation of the cytosolic DNA sensor cyclic GMP–AMP synthase (cGAS), preventing its activation by DENV-induced mitochondrial DNA release.
Siu, G. K. et al. Hepatitis C virus NS5A protein cooperates with phosphatidylinositol 4-kinase IIIalpha to induce mitochondrial fragmentation. Sci. Rep. 6, 23464 (2016).
Ruggieri, V. et al. Hepatitis C virus, mitochondria and auto/mitophagy: exploiting a host defense mechanism. World J. Gastroenterol. 20, 2624–2633 (2014).
Paul, D. & Bartenschlager, R. Architecture and biogenesis of plus-strand RNA virus replication factories. World J. Virol. 2, 32–48 (2013). This review describes the different architectures of positive-strand RNA virus replication factories and discusses the mechanisms of their biogenesis and maintenance.
Le Sommer, C., Barrows, N. J., Bradrick, S. S., Pearson, J. L. & Garcia-Blanco, M. A. G protein-coupled receptor kinase 2 promotes flaviviridae entry and replication. PLOS Negl. Trop. Dis. 6, e1820 (2012).
Krishnan, M. N. et al. RNA interference screen for human genes associated with West Nile virus infection. Nature 455, 242–245 (2008).
Modis, Y., Ogata, S., Clements, D. & Harrison, S. C. Structure of the dengue virus envelope protein after membrane fusion. Nature 427, 313–319 (2004). This is an elegant study describing the three-dimensional structure of the soluble ectodomain of the dengue virus envelope protein in its trimeric, that is, post-fusion state. The structure was used to propose a model for membrane fusion by class II viral fusion proteins.
Zhang, X. et al. Structure of acidic pH dengue virus showing the fusogenic glycoprotein trimers. J. Virol. 89, 743–750 (2015).
Scaturro, P., Cortese, M., Chatel-Chaix, L., Fischl, W. & Bartenschlager, R. Dengue virus non-structural protein 1 modulates infectious particle production via interaction with the structural proteins. PLOS Pathog. 11, e1005277 (2015).
Yu, I. M. et al. Structure of the immature dengue virus at low pH primes proteolytic maturation. Science 319, 1834–1837 (2008). This is an elegant study showing that immature DENV particles undergo a reversible conformational change at acidic pH, rendering them accessible for furin cleavage. Upon cleavage in the trans -Golgi network, the pr cleavage product is retained on the virion to prevent premature membrane fusion.
Zayas, M., Long, G., Madan, V. & Bartenschlager, R. Coordination of hepatitis C virus assembly by distinct regulatory regions in nonstructural protein 5A. PLOS Pathog. 12, e1005376 (2016).
Lee, J. Y. et al. Apolipoprotein E likely contributes to a maturation step of infectious hepatitis C virus particles and interacts with viral envelope glycoproteins. J. Virol. 88, 12422–12437 (2014).
Fukuhara, T. et al. Host-derived apolipoproteins play comparable roles with viral secretory proteins Erns and NS1 in the infectious particle formation of Flaviviridae. PLOS Pathog. 13, e1006475 (2017).
Piver, E. et al. Ultrastructural organisation of HCV from the bloodstream of infected patients revealed by electron microscopy after specific immunocapture. Gut 66, 1487–1495 (2016).
Yang, Z. et al. Neglected but important role of apolipoprotein E exchange in hepatitis C virus infection. J. Virol. 90, 9632–9643 (2016).
Bankwitz, D. et al. Maturation of secreted HCV particles by incorporation of secreted ApoE protects from antibodies by enhancing infectivity. J. Hepatol. 67, 480–489 (2017).
Acosta, E. G. & Bartenschlager, R. The quest for host targets to combat dengue virus infections. Curr. Opin. Virol. 20, 47–54 (2016).
Zeisel, M. B., Crouchet, E., Baumert, T. F. & Schuster, C. Host-targeting agents to prevent and cure hepatitis C virus infection. Viruses 7, 5659–5685 (2015).
Pawlotsky, J. M. et al. Alisporivir plus ribavirin, interferon free or in combination with pegylated interferon, for hepatitis C virus genotype 2 or 3 infection. Hepatology 62, 1013–1023 (2015).
Zeuzem, S. et al. Randomised clinical trial: alisporivir combined with peginterferon and ribavirin in treatment-naive patients with chronic HCV genotype 1 infection (ESSENTIAL II). Aliment. Pharmacol. Ther. 42, 829–844 (2015).
Low, J. G. et al. Efficacy and safety of celgosivir in patients with dengue fever (CELADEN): a phase 1b, randomised, double-blind, placebo-controlled, proof-of- concept trial. Lancet Infect. Dis. 14, 706–715 (2014).
Sung, C. et al. Extended evaluation of virological, immunological and pharmacokinetic endpoints of CELADEN: a randomized, placebo-controlled trial of celgosivir in dengue fever patients. PLOS Negl. Trop. Dis. 10, e0004851 (2016).
Watanabe, S. et al. Optimizing celgosivir therapy in mouse models of dengue virus infection of serotypes 1 and 2: the search for a window for potential therapeutic efficacy. Antiviral Res. 127, 10–19 (2016).
US National Library of Medicine. ClinicalTrials.gov http://www.clinicaltrials.gov/ct2/show/NCT02569827 (2017).
Acknowledgements
The authors apologize to all colleagues whose work they could not cite due to space limitations. Research in the authors' laboratory is supported by the Deutsche Forschungsgemeinschaft (SFB 1129, TP 11; SFB/TRR 83, TP 13; SFB/TRR179, TP 9), the Federal Ministry for Education and Research (BMBF) 'ERA-Net for Applied Systems Biology' (ERASysAPP) (SysVirDrug, grant no. 031A602B) and the EU H2020 project 'ANTIVIRALS' (grant no. 642434), all to R.B. C.J.N. is supported by the European Molecular Biology Organization (EMBO) (ALTF 466–2016).
Author information
Authors and Affiliations
Contributions
C.J.N., M.C. and E.G.A. researched data for the article. C.J.N., M.C., E.G.A. and R.B. substantially contributed to discussion of content, wrote the article and reviewed and edited the manuscript before submission.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Glossary
- Guillain–Barré syndrome
-
An acute neurological disease (usually reversible) resulting from autoimmune destruction of the peripheral nervous system that is frequently triggered by infection.
- Microcephaly
-
A neurological condition of abnormal brain development that causes substantially smaller infant head circumferences relative to age-matched controls.
- Tropism
-
Tissue specificity of a virus. Tropism is determined primarily by the presence of membrane receptors that can be exploited by the virus to gain access to host cells.
- Internal ribosome entry site
-
(IRES). A folded RNA element capable of recruiting the small ribosomal subunit that also mediates cap-independent initiation of RNA translation. IRES elements require only a subset of the canonical translation initiation factors, which are determined by the specific type of IRES.
- Polyprotein
-
A polypeptide composed of individual domains that are released both co-translationally and post-translationally by proteolytic cleavage to produce functionally distinct proteins.
- Very-low-density lipoprotein
-
(VLDL). A liver-produced plasma lipoprotein particle ∼30–70 nm in diameter involved in cholesterol and triglyceride transport. Low-density lipoprotein and VLDL contain distinct sets of apolipoproteins.
- Cyclophilin
-
Peptidyl-prolyl isomerases (PPIases) that catalyse the cis–trans isomerization of peptide bonds at proline residues and facilitate protein folding.
- Oligosaccharyltransferase
-
(OST). A heteromeric transmembrane protein complex located in the endoplasmic reticulum lumen that catalyses the transfer of a pre-assembled oligosaccharide to selected asparagine residues within the consensus sequence Asn-X-Ser/Thr of nascent polypeptides.
- Ubiquitin-dependent proteasome system
-
(UPS). A multicomponent system for regulated protein degradation. Proteins are marked for degradation by conjugation with the ubiquitin polypeptide through the concerted action of modular conjugation machinery. Ubiquitylated substrates are recognized, unfolded and degraded by a large multisubunit protease complex called the proteasome.
- CRISPR–Cas9
-
A site-specific gene-editing system derived from a bacterial adaptive defence system that retains foreign DNA in the CRISPR gene locus. The system is composed of a guide RNA homologous to the target gene and the CRISPR–Cas9 nuclease. Sequence complementarity guides Cas9 to the specific region targeted for cleavage.
- Bortezomib
-
A dipeptide boronic acid derivate that reversibly inhibits the chymotryptic activity of the proteasome. It was the first therapeutic proteasome inhibitor approved by the FDA for clinical use as an anticancer drug.
- Restriction factors
-
Cellular factors that inhibit pathogen replication.
- AKT1–mTOR
-
An intracellular signalling pathway that regulates several cellular processes, including cell proliferation and survival.
- Exosomes
-
Small extracellular vesicles released directly from cells or upon fusion of multivesicular bodies with the plasma membrane.
- Lipophagy
-
An autophagic pathway that selectively targets lipid droplets and mobilizes lipids to be used for energy production.
- ER-phagy
-
An autophagic pathway that selectively sequesters and degrades portions of the endoplasmic reticulum.
- Parkin
-
An E3 ubiquitin ligase that is involved in autophagic elimination of damaged mitochondria (mitophagy). Mutations in the parkin gene are linked to autosomal recessive juvenile Parkinson disease.
- Sterol regulatory element-binding protein
-
(SREBP). A membrane-bound transcription factor that regulates the transcription of genes involved in fatty acids and cholesterol metabolism.
- Microfilament
-
Also known as actin filaments; a component of the cytoskeleton. Microfilaments range from 7–9 nm in diameter and are composed of actin polymers. Microfilaments are involved in several cellular processes, including cytokinesis, cell movement, endocytosis and muscle contraction.
- Septins
-
GTPases that assemble into repeated hetero-oligomers and polymerize into higher-order structures, such as rings or filaments. Septins are the fourth cytoskeletal component and take part in several cellular processes, such as cell division, migration and pathogen interactions.
- Interferon regulatory factor 3
-
(IRF3). A transcription factor that mediates the expression of type 1 interferons and interferon-stimulated genes.
- Dynamin 1-like protein
-
(DRP1). A GTPase of the dynamin superfamily that mediate mitochondrial outer membrane fission events.
Rights and permissions
About this article
Cite this article
Neufeldt, C., Cortese, M., Acosta, E. et al. Rewiring cellular networks by members of the Flaviviridae family. Nat Rev Microbiol 16, 125–142 (2018). https://doi.org/10.1038/nrmicro.2017.170
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrmicro.2017.170
This article is cited by
-
Nuclear membrane protein SUN2 promotes replication of flaviviruses through modulating cytoskeleton reorganization mediated by NS1
Nature Communications (2024)
-
Epidemiology, biology, pathogenesis, clinical manifestations, and diagnosis of dengue virus infection, and its trend in Ethiopia: a comprehensive literature review
Tropical Medicine and Health (2023)
-
Expression of dengue virus and Zika virus NS2B-NS3pro constructs alter cellular fatty acids, but co-expression with a Zika virus virus-like particle is detrimental to virus-like particle expression
BMC Research Notes (2023)
-
Zika virus M protein latches and locks the E protein from transitioning to an immature state after prM cleavage
npj Viruses (2023)
-
Zika virus remodelled ER membranes contain proviral factors involved in redox and methylation pathways
Nature Communications (2023)
